Lite Strategy LITS
NASDAQ LITS
$0.99 +0.05 (+4.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Cash from Investing Activities (2010 - 2026)

Lite Strategy (LITS) posted quarterly Cash from Investing Activities of $2.1 million for Q1 2026, up 268.72% quarter-over-quarter from $569000.0 in Q4 2025.

Lite Strategy (LITS) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Lite Strategy's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at $2.1 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities changed N/A year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at -$97.3 million (down 277.96% YoY), while the FY2025 annual figure was $35.2 million, down 28.47% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $2.1 million, up from $569000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $24.5 million in Q4 2023, with the low at -$100.0 million in Q3 2025.
  • The 5-year median for Cash from Investing Activities is $13.7 million (2022), against an average of $5.1 million.
  • The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities soared 196.49% in 2024, then tumbled 780.41% in 2025.
  • Lite Strategy's Cash from Investing Activities stood at $10.5 million in 2022, then jumped by 132.74% to $24.5 million in 2023, then declined by 16.58% to $20.5 million in 2024, then slumped by 97.22% to $569000.0 in 2025, then jumped by 268.72% to $2.1 million in 2026.
  • Business Quant data shows LITS's Cash from Investing Activities at $2.1 million in Q1 2026, $569000.0 in Q4 2025, and -$100.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Lite Strategy 35.71 Mn 28.17 Mn - 2.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.10 Mn
Mar 31, 2026 2.10 Mn
Dec 31, 2025 569,000.00
Dec 31, 2025 569,000.00
Sep 30, 2025 -100.00 Mn
Sep 30, 2025 -100.00 Mn
Dec 31, 2024 20.45 Mn
Dec 31, 2024 20.45 Mn
Sep 30, 2024 14.70 Mn
Sep 30, 2024 14.70 Mn
Jun 30, 2024 19.54 Mn
Jun 30, 2024 19.54 Mn
Mar 31, 2024 122,000.00
Mar 31, 2024 122,000.00
Dec 31, 2023 24.52 Mn
Dec 31, 2023 24.52 Mn
Sep 30, 2023 4.96 Mn
Sep 30, 2023 4.96 Mn
Jun 30, 2023 19.40 Mn
Jun 30, 2023 19.40 Mn